Review




Structured Review

Moderna 2nd booster by moderna (ba.1)
Characteristics of Patients in Study Cohort
2nd Booster By Moderna (Ba.1), supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2nd booster by moderna (ba.1)/product/Moderna
Average 90 stars, based on 1 article reviews
2nd booster by moderna (ba.1) - by Bioz Stars, 2026-03
90/100 stars

Images

1) Product Images from "Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study"

Article Title: Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study

Journal: Open Forum Infectious Diseases

doi: 10.1093/ofid/ofad475

Characteristics of Patients in Study Cohort
Figure Legend Snippet: Characteristics of Patients in Study Cohort

Techniques Used: Infection

Vaccine Effectiveness After the Second or Third Booster Doses by Bivalent Vaccine Among Adults Aged ≥65 Years During Omicron BA.5 Predominance
Figure Legend Snippet: Vaccine Effectiveness After the Second or Third Booster Doses by Bivalent Vaccine Among Adults Aged ≥65 Years During Omicron BA.5 Predominance

Techniques Used: Infection



Similar Products

90
Moderna 2nd booster by moderna (ba.1)
Characteristics of Patients in Study Cohort
2nd Booster By Moderna (Ba.1), supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2nd booster by moderna (ba.1)/product/Moderna
Average 90 stars, based on 1 article reviews
2nd booster by moderna (ba.1) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Characteristics of Patients in Study Cohort

Journal: Open Forum Infectious Diseases

Article Title: Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study

doi: 10.1093/ofid/ofad475

Figure Lengend Snippet: Characteristics of Patients in Study Cohort

Article Snippet: 2nd Booster by Moderna (BA.1) , 35 (0.0).

Techniques: Infection

Vaccine Effectiveness After the Second or Third Booster Doses by Bivalent Vaccine Among Adults Aged ≥65 Years During Omicron BA.5 Predominance

Journal: Open Forum Infectious Diseases

Article Title: Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study

doi: 10.1093/ofid/ofad475

Figure Lengend Snippet: Vaccine Effectiveness After the Second or Third Booster Doses by Bivalent Vaccine Among Adults Aged ≥65 Years During Omicron BA.5 Predominance

Article Snippet: 2nd Booster by Moderna (BA.1) , 35 (0.0).

Techniques: Infection